VENUS CONCEPT INC (VERO) Fundamental Analysis & Valuation

NASDAQ:VERO • US92332W3034

1.14 USD
-0.04 (-3.39%)
At close: Feb 6, 2026
1.073 USD
-0.07 (-5.88%)
After Hours: 2/6/2026, 8:10:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This VERO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Overall VERO gets a fundamental rating of 1 out of 10. We evaluated VERO against 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of VERO have multiple concerns. VERO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. VERO Profitability Analysis

1.1 Basic Checks

  • VERO had negative earnings in the past year.
  • In the past year VERO has reported a negative cash flow from operations.
  • In the past 5 years VERO always reported negative net income.
  • VERO had a negative operating cash flow in each of the past 5 years.
VERO Yearly Net Income VS EBIT VS OCF VS FCFVERO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -88.62%, VERO is not doing good in the industry: 76.34% of the companies in the same industry are doing better.
  • With a Return On Equity value of -2043.17%, VERO is not doing good in the industry: 86.02% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -88.62%
ROE -2043.17%
ROIC N/A
ROA(3y)-47.85%
ROA(5y)-42.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VERO Yearly ROA, ROE, ROICVERO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

  • VERO has a Gross Margin of 64.36%. This is in the better half of the industry: VERO outperforms 67.74% of its industry peers.
  • VERO's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for VERO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 64.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.88%
GM growth 5Y-0.33%
VERO Yearly Profit, Operating, Gross MarginsVERO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. VERO Health Analysis

2.1 Basic Checks

  • VERO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • VERO has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, VERO has more shares outstanding
  • Compared to 1 year ago, VERO has an improved debt to assets ratio.
VERO Yearly Shares OutstandingVERO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
VERO Yearly Total Debt VS Total AssetsVERO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • VERO has an Altman-Z score of -9.05. This is a bad value and indicates that VERO is not financially healthy and even has some risk of bankruptcy.
  • VERO has a worse Altman-Z score (-9.05) than 74.73% of its industry peers.
  • VERO has a Debt/Equity ratio of 1.87. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.87, VERO is not doing good in the industry: 81.18% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.87
Debt/FCF N/A
Altman-Z -9.05
ROIC/WACCN/A
WACC2.68%
VERO Yearly LT Debt VS Equity VS FCFVERO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

  • A Current Ratio of 0.90 indicates that VERO may have some problems paying its short term obligations.
  • The Current ratio of VERO (0.90) is worse than 87.10% of its industry peers.
  • VERO has a Quick Ratio of 0.90. This is a bad value and indicates that VERO is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VERO has a worse Quick ratio (0.59) than 89.78% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.59
VERO Yearly Current Assets VS Current LiabilitesVERO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. VERO Growth Analysis

3.1 Past

  • VERO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.64%, which is quite impressive.
  • VERO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.39%.
  • VERO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.10% yearly.
EPS 1Y (TTM)44.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.78%
Revenue 1Y (TTM)-12.39%
Revenue growth 3Y-15.01%
Revenue growth 5Y-10.1%
Sales Q2Q%-8.2%

3.2 Future

  • The Earnings Per Share is expected to grow by 39.27% on average over the next years. This is a very strong growth
  • VERO is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.18% yearly.
EPS Next Y76.72%
EPS Next 2Y39.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-9.41%
Revenue Next 2Y-0.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VERO Yearly Revenue VS EstimatesVERO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
VERO Yearly EPS VS EstimatesVERO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1K -2K -3K -4K

More info and screens

Find the best growth stocksShow best growing peers

1

4. VERO Valuation Analysis

4.1 Price/Earnings Ratio

  • VERO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year VERO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VERO Price Earnings VS Forward Price EarningsVERO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VERO Per share dataVERO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 -40

4.3 Compensation for Growth

  • VERO's earnings are expected to grow with 39.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.27%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. VERO Dividend Analysis

5.1 Amount

  • No dividends for VERO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

VERO Fundamentals: All Metrics, Ratios and Statistics

VENUS CONCEPT INC

NASDAQ:VERO (2/6/2026, 8:10:22 PM)

After market: 1.073 -0.07 (-5.88%)

1.14

-0.04 (-3.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners15.62%
Inst Owner Change-7.83%
Ins Owners0.78%
Ins Owner Change0%
Market Cap2.12M
Revenue(TTM)58.88M
Net Income(TTM)-54.61M
Analysts43.33
Price TargetN/A
Short Float %1.55%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-125.03%
Min EPS beat(2)-229.69%
Max EPS beat(2)-20.38%
EPS beat(4)0
Avg EPS beat(4)-70.37%
Min EPS beat(4)-229.69%
Max EPS beat(4)-9.99%
EPS beat(8)0
Avg EPS beat(8)-58.53%
EPS beat(12)2
Avg EPS beat(12)-37.25%
EPS beat(16)3
Avg EPS beat(16)-40.32%
Revenue beat(2)1
Avg Revenue beat(2)-0.71%
Min Revenue beat(2)-6.74%
Max Revenue beat(2)5.33%
Revenue beat(4)1
Avg Revenue beat(4)-3.72%
Min Revenue beat(4)-9.08%
Max Revenue beat(4)5.33%
Revenue beat(8)2
Avg Revenue beat(8)-6.54%
Revenue beat(12)4
Avg Revenue beat(12)-4.13%
Revenue beat(16)5
Avg Revenue beat(16)-4.35%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.79
P/tB 7.12
EV/EBITDA N/A
EPS(TTM)-48.84
EYN/A
EPS(NY)-4.67
Fwd EYN/A
FCF(TTM)-11.16
FCFYN/A
OCF(TTM)-11
OCFYN/A
SpS31.65
BVpS1.44
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -88.62%
ROE -2043.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 64.36%
FCFM N/A
ROA(3y)-47.85%
ROA(5y)-42.26%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.88%
GM growth 5Y-0.33%
F-Score4
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 1.87
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.64%
Cap/Sales 0.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.59
Altman-Z -9.05
F-Score4
WACC2.68%
ROIC/WACCN/A
Cap/Depr(3y)4.54%
Cap/Depr(5y)6.03%
Cap/Sales(3y)0.23%
Cap/Sales(5y)0.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%13.78%
EPS Next Y76.72%
EPS Next 2Y39.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.39%
Revenue growth 3Y-15.01%
Revenue growth 5Y-10.1%
Sales Q2Q%-8.2%
Revenue Next Year-9.41%
Revenue Next 2Y-0.18%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-23.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-32.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.97%
OCF growth 3YN/A
OCF growth 5YN/A

VENUS CONCEPT INC / VERO FAQ

What is the ChartMill fundamental rating of VENUS CONCEPT INC (VERO) stock?

ChartMill assigns a fundamental rating of 1 / 10 to VERO.


What is the valuation status of VENUS CONCEPT INC (VERO) stock?

ChartMill assigns a valuation rating of 1 / 10 to VENUS CONCEPT INC (VERO). This can be considered as Overvalued.


Can you provide the profitability details for VENUS CONCEPT INC?

VENUS CONCEPT INC (VERO) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for VERO stock?

The Earnings per Share (EPS) of VENUS CONCEPT INC (VERO) is expected to grow by 76.72% in the next year.